immunocore.com (IMCR): Narxning prognoz qilingan daromadga nisbati

IMCR (Immunocore Holdings) - kompaniyaning tovar belgisi

Immunocore Holdings plc qattiq o'smalar va okulyar melanomaga qarshi kurashish uchun noyob TCR platformasidan foydalanadi. GURU.Markets terminali kompaniyaning kutilayotgan P/S grafigini namoyish etadi, bunda 3.30 qiymati joriy ko'rsatkichni ifodalaydi. Onkologiya sohasidagi ushbu Britaniya yutug'i brendga nisbatan shifokorlarning ishonchini qozondi. Kam uchraydigan saratonni davolashdagi yetakchilik yuqori marja va kuchli narx belgilash imkoniyatlarini kafolatlaydi.

IMCR Immunocore Holdings: Bozor kapitallashuvining kelajakdagi daromadga nisbati 04.07.2022 - 18.11.2026 oraligʻida

Immunocore Holdings plc (IMCR) kompaniyasining tahliliy kesimlari

- birja kapitallashuvi ma'lumotlari:
Kompaniyaning jamlanma tahlili:immunocore.com IMCR
Immunocore Corp tomonidan chiqariladigan mahsulotlar

Immunocore Holdings plc (IMCR) operatsion richagdan tadqiqot xarajatlarini optimallashtirish uchun foydalangan holda, tijorat kengayish bosqichiga o'tmoqda. Hozirgi hisoblangan 3.30 koeffitsiyenti bozor kapitalizatsiyasining kutilayotgan yillik daromadga nisbatini aks ettirib, kelajakdagi o'sish uchun premiumni o'lchaydi. Investorlar ushbu metrikadan aktivning kutilayotgan pul oqimlari nisbatida haddan tashqari sotib olinganligini baholash uchun foydalanadilar. GURU.Markets platformasida kompaniyaning kutilayotgan P/S tendentsiyasi bozor kayfiyatining o'zgarishini real vaqt rejimida baholash imkonini beradi.

Raqobatchilar tahlili

ImmunityBio Inc - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Janux Corp JANX|RCUS - Narxning prognoz qilingan daromadga nisbati|ZYME (zymeworks.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Tango Therapeutics Corp (TNGX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Iovance (IOVA)|Forvard narx/daromad multiplikatori IMTX|XNCR - Prognoz narxning daromadga nisbati|Forvard narx/daromad multiplikatori CMPX (Compass Bio)|Narxning kutilayotgan daromadga nisbati REPL|Forvard P/S multiplikatori LYEL (Lyell Immunopharma, Inc.)|Sotuvga nisbatan forvard narx IPHA|Pyxis - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Compugen|IO Biotech, Inc. (IOBT) - Narxning prognoz qilingan daromadga nisbati|Sutro Biopharma, Inc. - Sotuvga nisbatan forvard narx|INKT (minktherapeutics.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori werewolftx.com|Narxning prognoz qilingan daromadga nisbati immixbio.com (IMMX)|ALXO: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori CUE (Cue Biopharma Inc.)|PDS Biotechnology (PDSB) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SONN - Narxning prognoz qilingan daromadga nisbati|MAIA Biotechnology, Inc. (MAIA) - Forvard narx/daromad multiplikatori|LIMN: Forvard P/S multiplikatori|LAVA Therapeutics N.V. (LVTX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori NXTC|Forvard P/S multiplikatori leaptx.com|Forvard P/S multiplikatori INTS|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Sensei Biotherapeutics, Inc.|Forvard P/S multiplikatori TOVX (Theriva Corp)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati gritstonebio.com (GRTS)|kinetabio.com - Forvard P/S multiplikatori|NexImmune (NEXI) - Forvard narx/daromad multiplikatori|turnstonebio.com (TSBX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vaccinex, Inc (VCNX)|Forvard narx/daromad multiplikatori HARP